Deprenyl USA Inc. sales and marketing update

Deprenyl USA Inc. (DUSA) Deprenyl USA Inc. (DUSA) has granted Medicis Pharmaceutical Corp. (MDRXA) right of first refusal to market DUSA's Aminolevulinic Acid Photodynamic Therapy in the U.S. for tr...